ask="12.41"
ask_size="200"
average_daily_volume="1597180"
bid="9.76"
bid_size="100"
book_value="-0.09"
change="+0.11"
change_from_200_day_moving_average="-0.45"
change_from_50_day_moving_average="-1.55"
change_from_52_week_high="-6.18"
change_From_52_week_low="3.03"
change_in_percent="+1.11%"
close="9.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="94960000"
high="10.23"
high_52_weeks="16.17"
last_trade_date="1/3/2017"
last_trade_price="9.99"
last_trade_size="90399"
last_trade_time="4:00pm"
low="9.68"
low_52_weeks="6.96"
market_capitalization="1.28B"
moving_average_200_day="10.44"
moving_average_50_day="11.54"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.22"
open="10.09"
pe_ratio="N/A"
peg_ratio="-0.24"
percent_change_from_200_day_moving_average="-4.33%"
percent_change_from_50_day_moving_average="-13.45%"
percent_change_from_52_week_high="-38.22%"
percent_change_from_52_week_low="+43.53%"
previous_close="9.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="7.92"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="15.05"
stock_exchange="NMS"
symbol="HALO"
volume="1082510"
weeks_range_52="6.96 - 16.17"
